Signalling via CD131 regulates pulmonary inflammation, alveolar cell death and emphysema in COPD
Date
2025
Authors
Wang, H.
Fung, N.H.
Gamell, C.
Woodman, N.
Chan, S.
Lachapelle, P.
Vlahos, R.
McQualter, J.
Selemidis, S.
Galli, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
ERJ Open Research, 2025; 11(3):01020-2024-1-01020-2024-12
Statement of Responsibility
Hao Wang, Nok Him Fung, Cristina Gamell, Naomi Woodman, Samantha Chan, Philippe Lachapelle, Ross Vlahos, Jonathan McQualter, Stavros Selemidis, Mara Galli, Nick Wilson, Jo Douglass, Katherine Monaghan, Angel F. Lopez, Catherine Owczarek, and Steven Bozinovski
Conference Name
Abstract
Background: COPD is a heterogenous disease where chronic inflammation is implicated in airway remodelling and emphysema. The CD131 receptor is indispensable for signalling by the β common (βc) family of cytokines encompassing granulocyte−macrophage colony-stimulating factor, interleukin (IL)-5 and IL-3, which instigate both type-2 and non-type-2 inflammatory responses. This study aims to determine whether antagonising CD131 signalling can prevent pulmonary inflammation, alveolar cell death and emphysema development. Methods: We performed in-house and in silico transcriptomic analysis to investigate the gene expression of CD131 (CSF2RB) and pathway enrichment for βc cytokine signalling in blood, sputum and lung biopsies of COPD patients. To model emphysema, transgenic mice expressing human CD131 were exposed to elastase or cigarette smoke (CS) and a fully human monoclonal antibody (CSL311) was employed to inhibit CD131 signalling. Results: CD131 gene expression was significantly increased in COPD, along with an enrichment of gene set for βc cytokine signalling. In transgenic mice subjected to emphysema models, CD131 antagonism effectively prevented lung injury, alveolar cell death and emphysema development. Mechanistically, RNA sequencing identified pathway enrichment for myeloid cell activation, type-2 immune response and macrophage alternative activation in elastase-induced emphysematous mice, mirroring human COPD. Blocking CD131 signalling almost completely reversed the global gene expression alterations associated with emphysema development. Conclusions: CD131 signalling orchestrates pulmonary inflammation in COPD, resulting in immunopathology that underpins emphysema and lung function decline. Antagonising CD131 therefore represents a unique strategy to simultaneously target multiple pathogenic myeloid cell populations.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright ©The authors 2025 This version is distributed under the terms of the Creative Commons Attribution Non- Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org